EMA Backs Novo's Wegovy Pill, First Oral Weight-Loss Drug for Europe

EU regulator approves pill form of Novo Nordisk's Wegovy weight loss drug

Novo Nordisk has obtained approval for the pill form of its popular Wegovy anti-obesity drug in the European Union, the bloc's medicines regulator said on Friday.

Novo’s Wegovy Obesity Pill Recommended for Approval in Europe

The European Medicines Agency recommended approval for Novo Nordisk A/S’s Wegovy pill, the first of the powerful new weight-loss drugs to be available in oral form that is already approved in the US.

EMA backs Novo's Wegovy pill, first oral weight-loss drug for Europe

Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class

CHMP under (EMA) has adopted a positive opinion, recommending marketing authorisation of Wegovy® pill to reduce excess body weight...

Europe’s drugs regulator green-lights first oral weight-loss drug

Wegovy tablets offer a convenient alternative to the injectable version of the drug.